Primary Site >> Colorectal Cancer

Gene >> STK33

Journal: J Exp Med. 2012 Apr 9;209(4):697-711.
Title: Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33.
Author: Azoitei, Ninel|Hoffmann, Christopher M|Ellegast, Jana M|Ball, Claudia R|Obermayer, Kerstin|Gossele, Ulrike|Koch, Britta|Faber, Katrin|Genze, Felicitas|Schrader, Mark|Kestler, Hans A|Dohner, Hartmut|Chiosis, Gabriela|Glimm, Hanno|Frohling, Stefan|Scholl, C
PMID: 22451720
Journal: J Exp Clin Cancer Res. 2014 Jan 6;33:4.
Title: Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.
Author: Moon, Ji Wook|Lee, Soo Kyung|Lee, Jung Ok|Kim, Nami|Lee, Yong Woo|Kim, Su Jin|Kang, Ho Jin|Kim, Jin|Kim, Hyeon Soo|Park, Sun-Hwa
PMID: 24393480
Journal: Oncotarget. 2017 Aug 24;8(44):77474-77488.
Title: STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1alpha/VEGF signaling pathway.
Author: Liu, Yang|Steinestel, Konrad|Rouhi, Arefeh|Armacki, Milena|Diepold, Kristina|Chiosis, Gabriela|Simmet, Thomas|Seufferlein, Thomas|Azoitei, Ninel
PMID: 29100402
Journal: Oncol Lett. 2018 Feb;15(2):2153-2160.
Title: Role of serine/threonine kinase 33 methylation in colorectal cancer and its clinical significance.
Author: Yin, Ming-Di|Ma, Si-Ping|Liu, Fang|Chen, Yu-Ze
PMID: 29434919